Clinical Trials for Adults | Clinical and Neurocognitive Outcomes in Long-term Survivors of Primary Glioblastoma Multiforme
Primary Objective
To measure neurocognitive function in long-term survivors of primary GBM
Secondary Objectives
- to examine patient-reported measures (i.e. quality of life, fatigue, etc.)
- to identify patterns in retrospective neuropsychological testing from standardized neuropsychological testing batteries
- to identify tumor-related information (i.e. tumor location, number of recurrences, etc.)
- to identify clinical characteristics (i.e. neurological deficits, psychiatric illness, etc.)
- to identify image cytometry profiles